4//SEC Filing
KOS PHARMACEUTICALS INC 4
Accession 0001018952-05-000062
CIK 0001018952operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 2:26 PM ET
Size
10.3 KB
Accession
0001018952-05-000062
Insider Transaction Report
Form 4
BELL DANIEL M
Director
Transactions
- Sale
Common Stock, $.01 Par Value
2005-06-14$57.59/sh−10,000$575,900→ 35,846 total - Sale
Common Stock, $.01 Par Value
2005-06-14$57.60/sh−15,000$864,000→ 45,846 total - Exercise/Conversion
Common Stock, $.01 Par Value
2005-06-14$0.60/sh+25,000$15,000→ 60,846 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-06-14−25,000→ 15,000 totalExercise: $0.60From: 1996-06-20Exp: 2006-06-20→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Includes 10,820 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) plan and the Kos Employee Stock Purchase Plan.
Documents
Issuer
KOS PHARMACEUTICALS INC
CIK 0001018952
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001018952
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 2:26 PM ET
- Size
- 10.3 KB